COMMUNIQUÉS West-GlobeNewswire

NervGen to Host Inaugural R&D Day on September 30, 2026
09/09/2026
R&D Day to feature an in-depth review of NVG-291, including its nonclinical and translational foundation, broader therapeutic potential, clinical data generated to date, perspectives from the SCI community, and the [...]
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
09/09/2026
CEO Michael Halstead to participate in a fireside chat on Monday, September 14, 2026 at 9:00 a.m. EDT NEW YORK and TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” [...]
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
09/09/2026
- Independent Safety Monitoring Committee recommends advancement to Cohort 2 following blinded review of Cohort 1 safety and tolerability data – - Pharmacokinetic observations at the lowest dose evaluated were [...]
Pharming Group to participate in September investor conferences
09/09/2026
Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the [...]
Allegro’s Hydrocelin significantly improves knee osteoarthritis pain and function in clinical trial
09/09/2026
Nanotechnology-based injection significantly improved knee pain and function with favorable safety and efficacy sustained over 6 months following a single administration Feasibility trial in Belgium completed [...]
Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026
09/09/2026
Industry symposium to explore local delivery of combination antibiotics across spine and arthroplasty Poster showcases the efficacy of STIMULAN ® calcium sulfate beads, loaded with a combination of Gram-positive and [...]
ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
09/09/2026
Investment supports application of ViaNautis’ polyNaut ® platform to regenerative therapies for spinal cord injury, where targeted delivery remains a huge barrier Adds a new high-value CNS indication and provides [...]
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
09/09/2026
- Treatment with oral infigratinib for 52 weeks in PROPEL 3 resulted in favorable trends against placebo in clinically meaningful exploratory endpoints including sleep apnea and otitis media events Stabilization of [...]
Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
09/09/2026
Bâle (Suisse) et Chassieu (France) , 09 sept. 2026 (GLOBE NEWSWIRE) -- Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide Cet accord [...]
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
09/09/2026
Basel, Switzerland and Chassieu, France, , Sept. 09, 2026 (GLOBE NEWSWIRE) -- The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first [...]
Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia
09/09/2026
Innovate UK grant supports Athernal’s mission to intercept high-risk leukaemia before cancer develops Funding reflects growing confidence in cancer interception as an emerging therapeutic approach London, UK, September [...]
Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
09/09/2026
Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantation Round was led by NBank Capital with participation from CARMA FUND, Life Science Valley [...]
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
09/09/2026
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. ( [...]
GENFIT présente le potentiel commercial à long terme de sa technologie de diagnostic dans la MASH
09/09/2026
Un test sanguin simple, fiable et déployable à grande échelle permettrait d’identifier les patients atteints de MASH à risque parmi les près de 90 millions d’Américains bénéficiant d’un suivi médical en raison de [...]
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
09/09/2026
Simple, reliable and scalable blood-based testing could identify patients with at-risk MASH among nearly 90 million U.S. individuals receiving medical attention due to MASLD-related risk factors IQVIA estimates U.S peak [...]
ICG-21 Opens in Shenzhen, Spotlighting Bio-Generative Intelligence for Health and New Frontiers in Genomics
09/09/2026
SHENZHEN, China, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The 21st Annual Meeting of the International Conference on Genomics (ICG-21) was held at the BGI Center in Shenzhen from September 7 to 8. Under the theme “Bio- [...]
InnoCare Announces Approval of Clinical Trial of Novel Bispecific ADC ICP-B381 Targeting PSMA/ STEAP1 in China
09/09/2026
BEIJING, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
08/09/2026
– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes – – Cash runway remains projected into 2029, including the first $75 million [...]
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer
08/09/2026
Experienced finance executive and former Big Four auditor to lead corporate finance strategy, and capital markets initiatives PARAMUS, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a [...]

Pages